Related Experiment Video
Updated: Jul 20, 2026
Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
A high-throughput loss-of-function screening identifies novel p53 regulators
Susana Llanos1, Alejo Efeyan, Jorge Monsech
1Tumor Suppression Group, Spanish National Cancer Center (CNIO), Madrid, Spain.
Abstract:
The p53 protein is a sequence-specific transcription factor that plays a crucial role in tumor suppression by inducing apoptosis or cell cycle arrest in response to cellular damage. To identify novel proteins involved in the regulation of p53 transcriptional activity we have performed a large scale RNA interference-based screen. We have identified four genes previously unknown to be involved in modulating p53 activity (GAS41, RPS6K4, RUNDC1 and CRMP-2). The interference of each of these four genes resulted in the upregulation of p53 transcriptional activity and, conversely, their overexpression resulted in the inhibition of p53 target promoters and p53-mediated apoptosis. These observations suggest a role for these genes as p53 inhibitors and imply that they may have oncogenic activity.
Insights
Researchers identified four novel genes that inhibit tumor suppressor p53 (protein 53) activity. Modulating these genes impacts p53
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- The p53 protein is a critical tumor suppressor, regulating apoptosis and cell cycle arrest.
- Understanding p53 regulation is key to developing cancer therapies.
Purpose of the Study:
- To identify novel proteins that regulate p53 transcriptional activity.
- To investigate the role of these newly identified proteins in p53-mediated cellular processes.
Main Methods:
- A large-scale RNA interference (RNAi) screen was employed to identify regulatory proteins.
- Gene interference and overexpression studies were conducted to validate findings.
Main Results:
- Four previously unrecognized genes (GAS41, RPS6K4, RUNDC1, and CRMP-2) were identified as p53 modulators.
- Interference with these genes upregulated p53 transcriptional activity.
- Overexpression of these genes inhibited p53 target promoters and p53-mediated apoptosis.
Conclusions:
- GAS41, RPS6K4, RUNDC1, and CRMP-2 function as inhibitors of p53.
- These identified genes may possess oncogenic activity, highlighting potential therapeutic targets.
More Related Videos
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
09:33Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor
Published on: August 25, 2023
Related Concept Videos
02:46Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
02:23Abnormal Proliferation
01:23Negative Regulator Molecules